Legal & General Group’s Enliven Therapeutics ELVN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $691K | Buy |
|
|||||
|
2025
Q2 | $646K | Buy |
|
|||||
|
2025
Q1 | $417K | Buy |
|
|||||
|
2024
Q4 | $476K | Buy |
|
|||||
|
2024
Q3 | $519K | Buy |
|
|||||
|
2024
Q2 | $472K | Sell |
|
|||||
|
2024
Q1 | $363K | Buy |
|
|||||
|
2023
Q4 | $272K | Hold |
|
|||||
|
2023
Q3 | $269K | Buy |
|
|||||
|
2023
Q2 | $369K | Buy |
|
|||||
|
2021
Q2 | – | Sell |
|
|||||
|
2021
Q1 | $8K | Buy |
|
|||||
|
2020
Q4 | $19K | Buy |
|
|||||
|
2020
Q3 | $13K | Sell |
|
|||||
|
2020
Q2 | $22K | Buy |
|